BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 24477574)

  • 1. Genetic imbalances detected by multiplex ligation-dependent probe amplification in a cohort of patients with oral squamous cell carcinoma-the first step towards clinical personalized medicine.
    Ribeiro IP; Marques F; Caramelo F; Ferrão J; Prazeres H; Julião MJ; Rifi W; Savola S; de Melo JB; Baptista IP; Carreira IM
    Tumour Biol; 2014 May; 35(5):4687-95. PubMed ID: 24477574
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytogenetic alterations and their molecular genetic correlates in head and neck squamous cell carcinoma: a next generation window to the biology of disease.
    Gollin SM
    Genes Chromosomes Cancer; 2014 Dec; 53(12):972-90. PubMed ID: 25183546
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Microtubule-Associated Protein ATIP3, an Emerging Target for Personalized Medicine in Breast Cancer.
    Haykal MM; Rodrigues-Ferreira S; Nahmias C
    Cells; 2021 May; 10(5):. PubMed ID: 34062782
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A seven-gene signature to predict the prognosis of oral squamous cell carcinoma.
    Ribeiro IP; Esteves L; Santos A; Barroso L; Marques F; Caramelo F; Melo JB; Carreira IM
    Oncogene; 2021 Jun; 40(22):3859-3869. PubMed ID: 33972685
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Apoptosis and genes involved in oral cancer - a comprehensive review.
    Dwivedi R; Pandey R; Chandra S; Mehrotra D
    Oncol Rev; 2020 Jul; 14(2):472. PubMed ID: 32685111
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Upper aerodigestive tract carcinoma: Development of a (epi)genomic predictive model for recurrence and metastasis.
    Ribeiro IP; Caramelo F; Ribeiro M; Machado A; Miguéis J; Marques F; Carreira IM; Melo JB
    Oncol Lett; 2020 May; 19(5):3459-3468. PubMed ID: 32269619
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cytogenetics and Cytogenomics Evaluation in Cancer.
    Ribeiro IP; Melo JB; Carreira IM
    Int J Mol Sci; 2019 Sep; 20(19):. PubMed ID: 31547595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Head and neck cancer: searching for genomic and epigenetic biomarkers in body fluids - the state of art.
    Ribeiro IP; de Melo JB; Carreira IM
    Mol Cytogenet; 2019; 12():33. PubMed ID: 31333762
    [TBL] [Abstract][Full Text] [Related]  

  • 9. (Cyto)genomic and epigenetic characterization of BICR 10 cell line and three new established primary human head and neck squamous cell carcinoma cultures.
    Ribeiro IP; Rodrigues JM; Mascarenhas A; Marques V; Caramelo F; Julião MJ; Liehr T; Melo JB; Carreira IM
    Genes Genomics; 2019 Oct; 41(10):1207-1221. PubMed ID: 31321735
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a set of novel and robust gene expression signatures predicting prostate cancer recurrence.
    Jiang Y; Mei W; Gu Y; Lin X; He L; Zeng H; Wei F; Wan X; Yang H; Major P; Tang D
    Mol Oncol; 2018 Sep; 12(9):1559-1578. PubMed ID: 30024105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genomic and epigenetic signatures associated with survival rate in oral squamous cell carcinoma patients.
    Ribeiro IP; Caramelo F; Esteves L; Oliveira C; Marques F; Barroso L; Melo JB; Carreira IM
    J Cancer; 2018; 9(11):1885-1895. PubMed ID: 29896272
    [No Abstract]   [Full Text] [Related]  

  • 12. Genomic predictive model for recurrence and metastasis development in head and neck squamous cell carcinoma patients.
    Ribeiro IP; Caramelo F; Esteves L; Menoita J; Marques F; Barroso L; Miguéis J; Melo JB; Carreira IM
    Sci Rep; 2017 Oct; 7(1):13897. PubMed ID: 29066758
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genomic profile of oral squamous cell carcinomas with an adjacent leukoplakia or with an erythroleukoplakia that evolved after the treatment of primary tumor: A report of two cases.
    Ribeiro IP; Marques F; Barroso L; Rodrigues J; Caramelo F; Melo JB; Carreira IM
    Mol Med Rep; 2017 Nov; 16(5):6780-6786. PubMed ID: 28901451
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Genetic and epigenetic characterization of the tumors in a patient with a tongue primary tumor, a recurrence and a pharyngoesophageal second primary tumor.
    Ribeiro IP; Marques F; Barroso L; Miguéis J; Caramelo F; Santos A; Julião MJ; Melo JB; Carreira IM
    Mol Cytogenet; 2017; 10():13. PubMed ID: 28413448
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early detection and personalized treatment in oral cancer: the impact of omics approaches.
    Ribeiro IP; Barroso L; Marques F; Melo JB; Carreira IM
    Mol Cytogenet; 2016; 9():85. PubMed ID: 27895714
    [TBL] [Abstract][Full Text] [Related]  

  • 16. WT1, MSH6, GATA5 and PAX5 as epigenetic oral squamous cell carcinoma biomarkers - a short report.
    Ribeiro IP; Caramelo F; Marques F; Domingues A; Mesquita M; Barroso L; Prazeres H; Julião MJ; Baptista IP; Ferreira A; Melo JB; Carreira IM
    Cell Oncol (Dordr); 2016 Dec; 39(6):573-582. PubMed ID: 27491556
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Circulating miR-205: a promising biomarker for the detection and prognosis evaluation of bladder cancer.
    Fang Z; Dai W; Wang X; Chen W; Shen C; Ye G; Li L
    Tumour Biol; 2016 Jun; 37(6):8075-82. PubMed ID: 26715266
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genome-Wide Loss of Heterozygosity and DNA Copy Number Aberration in HPV-Negative Oral Squamous Cell Carcinoma and Their Associations with Disease-Specific Survival.
    Chen C; Zhang Y; Loomis MM; Upton MP; Lohavanichbutr P; Houck JR; Doody DR; Mendez E; Futran N; Schwartz SM; Wang P
    PLoS One; 2015; 10(8):e0135074. PubMed ID: 26247464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical and Genetic Factors Associated with Cutaneous Squamous Cell Carcinoma in Kidney and Heart Transplant Recipients.
    Sanders ML; Karnes JH; Denny JC; Roden DM; Ikizler TA; Birdwell KA
    Transplant Direct; 2015 May; 1(4):. PubMed ID: 26146661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. DNA methylome analysis identifies epigenetic silencing of FHIT as a determining factor for radiosensitivity in oral cancer: an outcome-predicting and treatment-implicating study.
    Lin HY; Hung SK; Lee MS; Chiou WY; Huang TT; Tseng CE; Shih LY; Lin RI; Lin JM; Lai YH; Chang CB; Hsu FC; Chen LC; Tsai SJ; Su YC; Li SC; Lai HC; Hsu WL; Liu DW; Tai CK; Wu SF; Chan MW
    Oncotarget; 2015 Jan; 6(2):915-34. PubMed ID: 25460508
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.